Research Peptide

FOXO4-DRI

PH-FOXO4-001
≥99%HPLC Verified
FOXO4-DRI research peptide, ≥99% purity

Specifications

Catalog NumberPH-FOXO4-001
Purity (HPLC)≥99%
Molecular Weight3400 Da
SequenceD-retro-inverso peptide

Description

FOXO4-DRI is a cell-penetrating peptide designed to selectively induce apoptosis in senescent cells. This senolytic peptide disrupts the FOXO4-p53 interaction that maintains senescent cell viability.

Mechanism of Action

FOXO4-DRI is a D-retro-inverso peptide that interferes with the FOXO4-p53 axis in senescent cells. By disrupting this interaction, the peptide releases p53 to trigger apoptosis selectively in senescent cells while sparing healthy cells (Baar et al., 2017). Studies show efficacy in removing senescent chondrocytes (PMID: 33996787) and alleviating age-related testosterone decline (PMID: 31959736).

Research Applications

Product Specifications

  • Purity: ≥99% (HPLC verified)
  • Molecular Weight: ~3000 Da
  • Form: Lyophilized powder
  • Storage: -20°C, protected from light

References

  1. Baar MP, et al. Cell. 2017. PMID: 28340339
  2. Chondrocyte senolysis study. 2021. PMID: 33996787
  3. Testosterone secretion study. 2020. PMID: 31959736

Documentation

COA
Certificate of AnalysisHPLC chromatogram, mass spectrometry, and batch documentation

Storage and Handling

  • ❄️ Store lyophilized peptide at -20°C or below
  • 🔒 Protect from light and moisture
  • 🌡️ Allow vial to reach room temperature before opening
  • 💧 Reconstitute with appropriate sterile solvent
  • 📦 Aliquot to avoid repeated freeze-thaw cycles

Research Overview

FOXO4-DRI is a synthetic peptide compound used in laboratory research settings. Researchers studying longevity and cellular aging research use this compound to investigate cellular signaling pathways, receptor binding affinities, and structure-activity relationships. Each batch is manufactured under controlled conditions and verified through HPLC and mass spectrometry analysis to ensure consistency across experimental replicates.